{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:23:02Z","timestamp":1780554182554,"version":"3.54.1"},"reference-count":66,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"National Institute on Drug Abuse, National Institutions of Health","award":["K08DA049905"],"award-info":[{"award-number":["K08DA049905"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In response to the opioid epidemic, addiction consultation services (ACS) increasingly provide dedicated hospital-based addiction treatment to patients with substance use disorder. We assessed hospitalist and medical staff perceptions of how the presence of 2 hospitals\u2019 ACS impacted care for hospitalized patients with opioid use disorder (OUD). We inquired about ongoing challenges in caring for this patient population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a qualitative study of hospital-based providers utilizing focus groups and key informant interviews for data collection. Transcripts were analyzed using a mixed inductive-deductive approach. Emergent themes were identified through an iterative, multidisciplinary team\u2013based process using a directed content analysis approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Hospitalists ( n\u2009=\u200920), nurses ( n\u2009=\u200913), social workers ( n\u2009=\u200911), and pharmacists ( n\u2009=\u200918) from a university hospital and a safety-net hospital in Colorado participated in focus groups or key informant interviews. In response to the availability of an ACS, hospitalists described increased confidence using methadone and buprenorphine to treat opioid withdrawal, which they perceived as contributing to improved patient outcomes and greater job satisfaction. Participants expressed concern about inconsistent care provided to patients with OUD that varied by the admitting team's specialty and the physician's background and training. Nurses and hospitalists reported frustrations with achieving adequate pain control among patients with OUD. Last, pharmacists reported practice variations when physicians dosed buprenorphine for acute pain among patients with OUD. A lack of standardized dosing led to concerns of inadequate analgesia or return to opioid use following hospital discharge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>An ACS reportedly supports hospitalists and medical staff to best care for hospitalized patients with OUD. Notably, care provided to patients with OUD may not be uniform depending on various physician-level factors. Future work to address the concerns reported by study participants may include education for OUD treatment, early involvement of the ACS, and incorporation of buprenorphine prescribing algorithms to standardize care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1080\/08897077.2021.1975873","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T22:36:18Z","timestamp":1634769378000},"page":"615-622","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":28,"title":["Experiences with an Addiction Consultation Service on Care Provided to Hospitalized Patients with Opioid use Disorder: A Qualitative Study of Hospitalists, Nurses, Pharmacists, and Social Workers"],"prefix":"10.1177","volume":"43","author":[{"given":"Catherine","family":"Callister","sequence":"first","affiliation":[{"name":"Division of Hospital Medicine, University of Colorado, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Lockhart","sequence":"additional","affiliation":[{"name":"Adult and Child Consortium for Health Outcomes Research and Delivery Service, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi Summers","family":"Holtrop","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Colorado, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Hoover","sequence":"additional","affiliation":[{"name":"Clinical Science Graduate Program, University of Colorado, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Calcaterra","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine, University of Colorado, Aurora, Colorado, USA"},{"name":"Division of General Internal Medicine, University of Colorado, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,1,1]]},"reference":[{"key":"bibr1-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.10.082"},{"key":"bibr2-08897077.2021.1975873","volume-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","author":"Weiss AJ","year":"2006"},{"key":"bibr3-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229174"},{"key":"bibr4-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024459"},{"key":"bibr5-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2019.1635964"},{"key":"bibr6-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"bibr7-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1111\/add.14188"},{"key":"bibr8-08897077.2021.1975873","first-page":"CD002209","volume":"2","author":"Mattick RP","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"bibr9-08897077.2021.1975873","first-page":"1000138","volume":"4","author":"Noska A","year":"2015","journal-title":"J Addict Behav Ther Rehabil"},{"key":"bibr10-08897077.2021.1975873","unstructured":"US Department of Justice DEA, Diversion Control Divsion. Title 21 Code of Federal Regulations: PART 1306 \u2014 PRESCRIPTIONS: \u00a71306.07 Administering or dispensing of narcotic drugs. DRUG ENFORCEMENT ADMINISTRATION. https:\/\/www.deadiversion.usdoj.gov\/21cfr\/cfr\/1306\/1306_07.htm. Published 2020. Accessed May 19, 2021."},{"key":"bibr11-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.09.024"},{"key":"bibr12-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.06.008"},{"key":"bibr13-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.5852"},{"key":"bibr14-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107"},{"key":"bibr15-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-06849-8"},{"key":"bibr16-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1111\/add.15383"},{"key":"bibr17-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2018.03.001"},{"key":"bibr18-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05251-9"},{"key":"bibr19-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-05966-0"},{"key":"bibr20-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-017-4077-z"},{"key":"bibr21-08897077.2021.1975873","unstructured":"Association AH. Addressing the opioid epidemic-resources. https:\/\/www.aha.org\/advocacy\/access-and-health-coverage\/access-behavioral-health\/opioids. Published 2018. Accessed September 26, 2020."},{"key":"bibr22-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000496"},{"issue":"11","key":"bibr23-08897077.2021.1975873","first-page":"752","volume":"13","author":"Englander H","year":"2018","journal-title":"J Hosp Med"},{"key":"bibr24-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2020.1748169"},{"key":"bibr25-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000314"},{"key":"bibr26-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05311-0"},{"key":"bibr27-08897077.2021.1975873","first-page":"1","volume-title":"The Sage Handbook of Qualitative Research","author":"Denzin NK","year":"2005"},{"key":"bibr28-08897077.2021.1975873","volume-title":"Qualitative Inquiry and Research Design: Choosing among Five Approaches","author":"Creswell JW","year":"2016"},{"key":"bibr29-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1177\/1049732307307031"},{"key":"bibr30-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1080\/17489539.2017.1394807"},{"key":"bibr31-08897077.2021.1975873","volume-title":"The Mixed Methods Research Workbook: Activities for Designing, Implementing, and Publishing Projects","author":"Fetters MD.","year":"2019"},{"key":"bibr32-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1177\/1525822X05279903"},{"key":"bibr33-08897077.2021.1975873","volume-title":"Focus Groups as Qualitative Research","volume":"16","author":"Morgan DL.","year":"1996"},{"key":"bibr34-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2015.1424"},{"key":"bibr35-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.15.1458"},{"key":"bibr36-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-0009.2005.00397.x"},{"key":"bibr37-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2016.1187240"},{"key":"bibr38-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"bibr39-08897077.2021.1975873","unstructured":"Analysis AtQD. Qualitative Data Analysis Software. https:\/\/atlasti.com\/. Published 2020. Accessed February 13, 2021."},{"key":"bibr40-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1177\/1049732305276687"},{"key":"bibr41-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.2307\/3348969"},{"key":"bibr42-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1177\/160940690600500107"},{"key":"bibr43-08897077.2021.1975873","unstructured":"Department of Veterans Affairs. VA\/DoD Clinical Practice Guideline for the Management of Substance Use Disorders. Washington, DC: Department of Veterans Affair\u2013Department of Defense United States of America; 2015."},{"key":"bibr44-08897077.2021.1975873","unstructured":"Gowing L, Ali R, Dunlop A, Farrell M, Lintzeris N. National guidelines for medication-assisted treatment of opioid dependence. Canberra: Commonwealth of Australia; 2014:77\u2013162."},{"key":"bibr45-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170958"},{"issue":"2","key":"bibr46-08897077.2021.1975873","first-page":"1","volume":"14","author":"Cunningham CE","year":"2020","journal-title":"J Addict Med"},{"key":"bibr47-08897077.2021.1975873","author":"Comer S","year":"2015","journal-title":"Am Soc Addicit Med"},{"key":"bibr48-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"bibr49-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207.pub2"},{"key":"bibr50-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002025.pub5"},{"key":"bibr51-08897077.2021.1975873","unstructured":"Medicine YDoE. ED-Initiated Buprenorphine. https:\/\/medicine.yale.edu\/edbup\/Algorithm_338052_5_v2.pdf. Published 2020. Updated 09\/24\/2019. Accessed February 12, 2021."},{"key":"bibr52-08897077.2021.1975873","unstructured":"Project CB. Buprenorphine hospital quick start. CA Bridge. https:\/\/cabridge.org\/resource\/buprenorphine-bup-hospital-quick-start\/. Published 2021. Accessed February 12, 2021."},{"key":"bibr53-08897077.2021.1975873","unstructured":"Substance Abuse and Mental Health Services Administration. Buprenorphine. https:\/\/www.samhsa.gov\/medication-assisted-treatment\/medications-counseling-related-conditions\/buprenorphine. Published 2021. Accessed 2021, May 20."},{"key":"bibr54-08897077.2021.1975873","unstructured":"Substance Abuse and Mental Health Services Administration.\n                      Federal Guidelines for Opioid Treatment Programs\n                      . HHS Publication No. (SMA) XX-XXXX. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015."},{"key":"bibr55-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/868746"},{"key":"bibr56-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-2-200601170-00010"},{"key":"bibr57-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.03.044"},{"key":"bibr58-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.3265"},{"key":"bibr59-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pny019"},{"key":"bibr60-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pny217"},{"key":"bibr61-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnaa020"},{"key":"bibr62-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-018-1255-3"},{"key":"bibr63-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.07.048"},{"key":"bibr64-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2006.03904.x"},{"key":"bibr65-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a2154"},{"key":"bibr66-08897077.2021.1975873","doi-asserted-by":"publisher","DOI":"10.1177\/2150132719885286"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2021.1975873","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2021.1975873","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2021.1975873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:55:48Z","timestamp":1777625748000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2021.1975873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1080\/08897077.2021.1975873"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2021.1975873","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}